Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes.
Bing-Li LiuXiao-Mei LiuYi-Fei RenYi-Xuan SunMeng-Hui LuoLei YeJian-Hua MaFeng-Fei LiPublished in: Journal of diabetes research (2020)
Our data indicate that male patients with T2D receiving mid-premixed insulin analogue regimen may have a potential benefit of improvement in glycemic control compared to female patients. This trial is registered with ClinicalTrials.gov ChiCTR-IPR-15007340.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- end stage renal disease
- ejection fraction
- newly diagnosed
- weight loss
- clinical trial
- prognostic factors
- peritoneal dialysis
- insulin resistance
- mental health
- study protocol
- randomized controlled trial
- metabolic syndrome
- big data
- skeletal muscle
- machine learning
- phase ii
- deep learning